CGTX 8-K: SEC filing

Cognition Therapeutics, Inc.

Filed with the SEC on · accession 0001104659-26-122952

CGTX filed a 8-K (current report) with the SEC on Nov 5, 2026. Cognition Therapeutics, Inc. filed a Form 8-K cover page dated November 3, 2026. The stock moved -7.0% by the first close after the filing.

Summary of the filing

Cognition Therapeutics, Inc. filed a Form 8-K cover page dated November 3, 2026. The filing contains only XBRL cover-page data with no substantive disclosure of a material event.

Key details

RegistrantCognition Therapeutics, Inc.

How CGTX stock reacted

Close before

$0.68

Nov 4, 2026

First close after

-7.01%

$0.64

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for CGTX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CGTX?

Click here

Frequently asked questions

What did CGTX file with the SEC on Nov 5, 2026?

CGTX filed a 8-K (SEC filing). Cognition Therapeutics, Inc. filed a Form 8-K cover page dated November 3, 2026. The filing contains only XBRL cover-page data with no substantive disclosure of a material event.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did CGTX stock react to this filing?

CGTX closed at $0.68 before the filing and $0.64 on Nov 5, 2026 (-7.01%).

Other CGTX SEC filings

Get alerts when CGTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days